25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

International Stem Cell Corp
Buy, Hold or Sell?

Let's analyze International Stem Cell Corp together

I guess you are interested in International Stem Cell Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of International Stem Cell Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about International Stem Cell Corp

I send you an email if I find something interesting about International Stem Cell Corp.

1. Quick Overview

1.1. Quick analysis of International Stem Cell Corp (30 sec.)










1.2. What can you expect buying and holding a share of International Stem Cell Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.50
Expected worth in 1 year
$-0.52
How sure are you?
52.5%

+ What do you gain per year?

Total Gains per Share
$-0.02
Return On Investment
-23.6%

For what price can you sell your share?

Current Price per Share
$0.09
Expected price per share
$0.06 - $0.1
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of International Stem Cell Corp (5 min.)




Live pricePrice per Share (EOD)
$0.09
Intrinsic Value Per Share
$1.67 - $2.00
Total Value Per Share
$1.17 - $1.50

2.2. Growth of International Stem Cell Corp (5 min.)




Is International Stem Cell Corp growing?

Current yearPrevious yearGrowGrow %
How rich?-$4m-$4.3m$284.5k7.0%

How much money is International Stem Cell Corp making?

Current yearPrevious yearGrowGrow %
Making money-$171k$34.5k-$205.5k-120.2%
Net Profit Margin-9.0%1.5%--

How much money comes from the company's main activities?

2.3. Financial Health of International Stem Cell Corp (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of International Stem Cell Corp?

Welcome investor! International Stem Cell Corp's management wants to use your money to grow the business. In return you get a share of International Stem Cell Corp.

First you should know what it really means to hold a share of International Stem Cell Corp. And how you can make/lose money.

Speculation

The Price per Share of International Stem Cell Corp is $0.09. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of International Stem Cell Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in International Stem Cell Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.50. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of International Stem Cell Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.0116.5%-0.02-23.7%0.0439.3%-0.04-40.9%-0.05-60.1%
Usd Book Value Change Per Share0.0334.4%-0.01-5.9%0.0219.9%-0.02-19.6%-0.01-14.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.0334.4%-0.01-5.9%0.0219.9%-0.02-19.6%-0.01-14.5%
Usd Price Per Share0.06-0.09-0.22-0.39-0.97-
Price to Earnings Ratio1.01--0.51--0.04--12.94--6.47-
Price-to-Total Gains Ratio1.94--20.95-4.87-3.88-78.53-
Price to Book Ratio-0.12--0.17--0.39--32.23--17.34-
Price-to-Total Gains Ratio1.94--20.95-4.87-3.88-78.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.09
Number of shares11111
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.02
Usd Total Gains Per Share-0.01-0.02
Gains per Quarter (11111 shares)-58.99-196.07
Gains per Year (11111 shares)-235.98-784.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-236-2460-784-794
20-472-4820-1569-1578
30-708-7180-2353-2362
40-944-9540-3137-3146
50-1180-11900-3921-3930
60-1416-14260-4706-4714
70-1652-16620-5490-5498
80-1888-18980-6274-6282
90-2124-21340-7059-7066
100-2360-23700-7843-7850

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%6.014.00.030.0%12.025.03.030.0%12.027.011.024.0%
Book Value Change Per Share1.03.00.025.0%6.06.00.050.0%10.010.00.050.0%21.019.00.052.5%24.026.00.048.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%4.00.046.08.0%
Total Gains per Share1.03.00.025.0%6.06.00.050.0%10.010.00.050.0%21.019.00.052.5%24.026.00.048.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of International Stem Cell Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.031-0.005+117%0.018+73%-0.018+157%-0.013+142%
Book Value Per Share---0.502-0.510+2%-0.545+9%-0.385-23%-0.170-66%
Current Ratio--0.7600.748+2%0.668+14%0.789-4%0.651+17%
Debt To Asset Ratio--1.7181.743-1%1.825-6%1.559+10%1.233+39%
Debt To Equity Ratio----0%-0%-0%2.749-100%
Dividend Per Share----0%-0%-0%-0%
Eps--0.015-0.021+244%0.035-58%-0.037+348%-0.054+464%
Free Cash Flow Per Share---0.012-0.003-76%0.025-148%-0.009-23%-0.038+220%
Free Cash Flow To Equity Per Share---0.012-0.003-76%0.025-148%0.024-149%0.045-126%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.925+8%
Intrinsic Value_10Y_max--2.004--------
Intrinsic Value_10Y_min--1.668--------
Intrinsic Value_1Y_max--0.039--------
Intrinsic Value_1Y_min--0.039--------
Intrinsic Value_3Y_max--0.242--------
Intrinsic Value_3Y_min--0.228--------
Intrinsic Value_5Y_max--0.592--------
Intrinsic Value_5Y_min--0.539--------
Market Cap720395.100+33%480263.400680373.150-29%1720943.850-72%3121712.100-85%9138578.893-95%
Net Profit Margin--0.051-0.090+275%0.015+246%-0.170+433%-0.270+629%
Operating Margin----0%-0.0640%-0.1610%-0.2680%
Operating Ratio--1.3281.489-11%1.471-10%1.552-14%1.402-5%
Pb Ratio-0.179-50%-0.120-0.168+40%-0.388+224%-32.227+26849%-17.343+14402%
Pe Ratio1.513+33%1.009-0.505+150%-0.041+104%-12.944+1383%-6.465+741%
Price Per Share0.090+33%0.0600.085-29%0.215-72%0.390-85%0.969-94%
Price To Free Cash Flow Ratio-1.876-50%-1.2510.880-242%4.095-131%-8.173+554%6.300-120%
Price To Total Gains Ratio2.905+33%1.937-20.952+1182%4.866-60%3.879-50%78.532-98%
Quick Ratio--0.1610.136+18%0.134+20%0.296-46%0.247-35%
Return On Assets--0.021-0.032+249%0.004+463%-0.057+366%-0.066+412%
Return On Equity----0%-0%-0%-0.1170%
Total Gains Per Share--0.031-0.005+117%0.018+73%-0.018+157%-0.013+142%
Usd Book Value---4016000.000-4081500.000+2%-4366000.000+9%-3084400.000-23%-1234350.000-69%
Usd Book Value Change Per Share--0.031-0.005+117%0.018+73%-0.018+157%-0.013+142%
Usd Book Value Per Share---0.502-0.510+2%-0.545+9%-0.385-23%-0.170-66%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.015-0.021+244%0.035-58%-0.037+348%-0.054+464%
Usd Free Cash Flow---96000.000-23000.000-76%199000.000-148%-74350.000-23%-296400.000+209%
Usd Free Cash Flow Per Share---0.012-0.003-76%0.025-148%-0.009-23%-0.038+220%
Usd Free Cash Flow To Equity Per Share---0.012-0.003-76%0.025-148%0.024-149%0.045-126%
Usd Market Cap720395.100+33%480263.400680373.150-29%1720943.850-72%3121712.100-85%9138578.893-95%
Usd Price Per Share0.090+33%0.0600.085-29%0.215-72%0.390-85%0.969-94%
Usd Profit--119000.000-171000.000+244%34500.000+245%-344500.000+389%-489300.000+511%
Usd Revenue--2331000.0002080500.000+12%2015000.000+16%1983300.000+18%2031150.000+15%
Usd Total Gains Per Share--0.031-0.005+117%0.018+73%-0.018+157%-0.013+142%
 EOD+6 -2MRQTTM+20 -10YOY+17 -135Y+12 -1810Y+19 -13

3.3 Fundamental Score

Let's check the fundamental score of International Stem Cell Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-151.513
Price to Book Ratio (EOD)Between0-1-0.179
Net Profit Margin (MRQ)Greater than00.051
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.161
Current Ratio (MRQ)Greater than10.760
Debt to Asset Ratio (MRQ)Less than11.718
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.021
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of International Stem Cell Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.198
Ma 20Greater thanMa 500.068
Ma 50Greater thanMa 1000.071
Ma 100Greater thanMa 2000.080
OpenGreater thanClose0.090
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About International Stem Cell Corp

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC-hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke, traumatic brain injury, and Alzheimer's disease. The company also offers anti-aging skin care products, including ProPlus Advanced Defense Complex, ProPlus Advanced Recovery Complex, ProPlus Eye Firming Complex, ProPlus Neck Firming Complex, ProPlus Advanced Aqueous Treatment, ProPlus Collagen Booster, ProPlus Elastin Booster, and ProPlus Brightening Toner. In addition, it provides human cell culture products comprising human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also consists of adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-09-09 11:43:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit International Stem Cell Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • A Net Profit Margin of 5.1% means that $0.05 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of International Stem Cell Corp:

  • The MRQ is 5.1%. The company is making a profit. +1
  • The TTM is -9.0%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ5.1%TTM-9.0%+14.1%
TTM-9.0%YOY1.5%-10.4%
TTM-9.0%5Y-17.0%+8.0%
5Y-17.0%10Y-27.0%+10.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1%-130.1%+135.2%
TTM-9.0%-207.9%+198.9%
YOY1.5%-215.4%+216.9%
5Y-17.0%-366.0%+349.0%
10Y-27.0%-473.1%+446.1%
4.3.1.2. Return on Assets

Shows how efficient International Stem Cell Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • 2.1% Return on Assets means that International Stem Cell Corp generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of International Stem Cell Corp:

  • The MRQ is 2.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is -3.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.1%TTM-3.2%+5.3%
TTM-3.2%YOY0.4%-3.5%
TTM-3.2%5Y-5.7%+2.5%
5Y-5.7%10Y-6.6%+1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%-10.8%+12.9%
TTM-3.2%-11.7%+8.5%
YOY0.4%-11.1%+11.5%
5Y-5.7%-12.6%+6.9%
10Y-6.6%-14.4%+7.8%
4.3.1.3. Return on Equity

Shows how efficient International Stem Cell Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • 0.0% Return on Equity means International Stem Cell Corp generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of International Stem Cell Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-11.7%+11.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.7%+13.7%
TTM--15.9%+15.9%
YOY--13.6%+13.6%
5Y--18.6%+18.6%
10Y-11.7%-19.0%+7.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of International Stem Cell Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient International Stem Cell Corp is operating .

  • Measures how much profit International Stem Cell Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of International Stem Cell Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-6.4%+6.4%
TTM-5Y-16.1%+16.1%
5Y-16.1%10Y-26.8%+10.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--279.4%+279.4%
TTM--315.9%+315.9%
YOY-6.4%-236.0%+229.6%
5Y-16.1%-384.8%+368.7%
10Y-26.8%-497.0%+470.2%
4.3.2.2. Operating Ratio

Measures how efficient International Stem Cell Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.33 means that the operating costs are $1.33 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of International Stem Cell Corp:

  • The MRQ is 1.328. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.489. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.328TTM1.489-0.161
TTM1.489YOY1.471+0.018
TTM1.4895Y1.552-0.063
5Y1.55210Y1.402+0.150
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3282.759-1.431
TTM1.4893.198-1.709
YOY1.4713.405-1.934
5Y1.5524.847-3.295
10Y1.4026.494-5.092
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of International Stem Cell Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if International Stem Cell Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.76 means the company has $0.76 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of International Stem Cell Corp:

  • The MRQ is 0.760. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.748. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.760TTM0.748+0.012
TTM0.748YOY0.668+0.081
TTM0.7485Y0.789-0.041
5Y0.78910Y0.651+0.138
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7603.793-3.033
TTM0.7483.978-3.230
YOY0.6684.741-4.073
5Y0.7896.077-5.288
10Y0.6516.356-5.705
4.4.3.2. Quick Ratio

Measures if International Stem Cell Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • A Quick Ratio of 0.16 means the company can pay off $0.16 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of International Stem Cell Corp:

  • The MRQ is 0.161. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.136. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.161TTM0.136+0.025
TTM0.136YOY0.134+0.002
TTM0.1365Y0.296-0.160
5Y0.29610Y0.247+0.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1613.256-3.095
TTM0.1363.548-3.412
YOY0.1344.763-4.629
5Y0.2965.935-5.639
10Y0.2476.494-6.247
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of International Stem Cell Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of International Stem Cell Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare International Stem Cell Corp to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.72 means that International Stem Cell Corp assets are financed with 171.8% credit (debt) and the remaining percentage (100% - 171.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of International Stem Cell Corp:

  • The MRQ is 1.718. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.743. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.718TTM1.743-0.025
TTM1.743YOY1.825-0.082
TTM1.7435Y1.559+0.184
5Y1.55910Y1.233+0.326
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7180.340+1.378
TTM1.7430.343+1.400
YOY1.8250.309+1.516
5Y1.5590.363+1.196
10Y1.2330.379+0.854
4.5.4.2. Debt to Equity Ratio

Measures if International Stem Cell Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of International Stem Cell Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y2.749-2.749
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.389-0.389
TTM-0.444-0.444
YOY-0.375-0.375
5Y-0.446-0.446
10Y2.7490.486+2.263
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings International Stem Cell Corp generates.

  • Above 15 is considered overpriced but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • A PE ratio of 1.01 means the investor is paying $1.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of International Stem Cell Corp:

  • The EOD is 1.513. Based on the earnings, the company is cheap. +2
  • The MRQ is 1.009. Based on the earnings, the company is cheap. +2
  • The TTM is -0.505. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.513MRQ1.009+0.504
MRQ1.009TTM-0.505+1.514
TTM-0.505YOY-0.041-0.464
TTM-0.5055Y-12.944+12.439
5Y-12.94410Y-6.465-6.479
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.513-2.331+3.844
MRQ1.009-2.367+3.376
TTM-0.505-2.936+2.431
YOY-0.041-3.453+3.412
5Y-12.944-6.040-6.904
10Y-6.465-6.227-0.238
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of International Stem Cell Corp:

  • The EOD is -1.876. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.251. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 0.880. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-1.876MRQ-1.251-0.625
MRQ-1.251TTM0.880-2.131
TTM0.880YOY4.095-3.214
TTM0.8805Y-8.173+9.054
5Y-8.17310Y6.300-14.473
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.876-2.972+1.096
MRQ-1.251-3.162+1.911
TTM0.880-3.470+4.350
YOY4.095-4.587+8.682
5Y-8.173-7.974-0.199
10Y6.300-8.394+14.694
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of International Stem Cell Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.12 means the investor is paying $-0.12 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of International Stem Cell Corp:

  • The EOD is -0.179. Based on the equity, the company is expensive. -2
  • The MRQ is -0.120. Based on the equity, the company is expensive. -2
  • The TTM is -0.168. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.179MRQ-0.120-0.060
MRQ-0.120TTM-0.168+0.048
TTM-0.168YOY-0.388+0.220
TTM-0.1685Y-32.227+32.060
5Y-32.22710Y-17.343-14.885
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1791.880-2.059
MRQ-0.1201.940-2.060
TTM-0.1682.198-2.366
YOY-0.3882.388-2.776
5Y-32.2273.622-35.849
10Y-17.3434.219-21.562
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Operating Income  -14447-97-327-424246-178327149



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets5,594
Total Liabilities9,610
Total Stockholder Equity-4,016
 As reported
Total Liabilities 9,610
Total Stockholder Equity+ -4,016
Total Assets = 5,594

Assets

Total Assets5,594
Total Current Assets3,819
Long-term Assets1,775
Total Current Assets
Cash And Cash Equivalents 1,290
Net Receivables 810
Inventory 1,415
Other Current Assets 11
Total Current Assets  (as reported)3,819
Total Current Assets  (calculated)3,526
+/- 293
Long-term Assets
Property Plant Equipment 746
Intangible Assets 758
Long-term Assets Other 240
Long-term Assets  (as reported)1,775
Long-term Assets  (calculated)1,744
+/- 31

Liabilities & Shareholders' Equity

Total Current Liabilities5,024
Long-term Liabilities4,586
Total Stockholder Equity-4,016
Total Current Liabilities
Short Long Term Debt 3,523
Accounts payable 377
Total Current Liabilities  (as reported)5,024
Total Current Liabilities  (calculated)3,900
+/- 1,124
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt588
Long-term Liabilities  (as reported)4,586
Long-term Liabilities  (calculated)588
+/- 3,998
Total Stockholder Equity
Total Stockholder Equity (as reported)-4,016
Total Stockholder Equity (calculated)0
+/- 4,016
Other
Capital Stock13
Common Stock Shares Outstanding 8,004
Net Debt 2,233
Net Invested Capital -498
Net Working Capital -1,205
Property Plant and Equipment Gross 3,127



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-30
> Total Assets 
8,112
7,325
10,586
8,909
7,116
5,370
6,815
6,098
6,927
7,739
6,652
6,615
6,364
7,179
6,693
6,885
7,230
7,138
8,388
7,861
7,540
7,045
7,855
7,614
7,953
6,864
7,468
8,416
8,725
7,796
8,663
8,541
8,260
6,620
6,876
6,783
5,851
5,287
6,019
5,611
4,937
4,946
5,501
5,416
5,042
5,135
5,341
5,786
5,641
5,390
5,369
5,594
5,5945,3695,3905,6415,7865,3415,1355,0425,4165,5014,9464,9375,6116,0195,2875,8516,7836,8766,6208,2608,5418,6637,7968,7258,4167,4686,8647,9537,6147,8557,0457,5407,8618,3887,1387,2306,8856,6937,1796,3646,6156,6527,7396,9276,0986,8155,3707,1168,90910,5867,3258,112
   > Total Current Assets 
5,543
4,611
0
0
0
0
0
0
0
4,626
3,535
3,213
2,877
0
0
0
3,593
2,991
4,133
3,320
3,137
2,492
3,274
2,796
3,133
2,855
3,410
4,340
4,692
3,770
3,512
3,328
3,259
3,452
3,380
3,398
2,631
2,183
3,046
2,786
2,486
2,334
2,960
2,994
2,700
2,963
3,236
3,684
3,658
3,521
3,593
3,819
3,8193,5933,5213,6583,6843,2362,9632,7002,9942,9602,3342,4862,7863,0462,1832,6313,3983,3803,4523,2593,3283,5123,7704,6924,3403,4102,8553,1332,7963,2742,4923,1373,3204,1332,9913,5930002,8773,2133,5354,62600000004,6115,543
       Cash And Cash Equivalents 
3,582
2,584
6,013
4,285
2,380
654
1,912
654
1,792
2,293
1,041
798
521
1,111
611
554
599
532
1,542
768
733
110
676
297
510
304
447
477
1,161
1,075
615
595
463
484
708
1,315
1,026
689
1,117
750
505
171
398
586
666
742
943
1,382
1,430
1,588
1,386
1,290
1,2901,3861,5881,4301,3829437426665863981715057501,1176891,0261,3157084844635956151,0751,1614774473045102976761107337681,5425325995546111,1115217981,0412,2931,7926541,9126542,3804,2856,0132,5843,582
       Short-term Investments 
0
0
0
0
0
0
0
50
50
50
50
50
50
50
50
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000005050505050505050500000000
       Net Receivables 
342
246
0
0
0
0
0
0
0
306
501
406
464
0
0
0
615
539
461
518
595
574
615
605
684
465
939
1,614
1,545
651
957
976
1,080
1,515
1,138
694
509
403
437
547
668
844
902
743
427
747
688
662
644
574
632
810
8106325746446626887474277439028446685474374035096941,1381,5151,0809769576511,5451,6149394656846056155745955184615396150004644065013060000000246342
       Inventory 
1,329
1,497
1,228
1,272
1,122
1,199
1,206
1,370
1,360
1,369
1,357
1,470
1,533
1,517
1,668
1,759
1,874
1,348
1,434
1,368
1,284
1,390
1,423
1,390
1,352
1,307
1,385
1,682
1,474
1,501
1,460
1,317
1,409
1,246
1,100
1,010
937
917
1,055
1,073
1,139
1,184
1,322
1,361
1,415
1,384
1,294
1,296
1,317
1,263
1,273
1,415
1,4151,2731,2631,3171,2961,2941,3841,4151,3611,3221,1841,1391,0731,0559179371,0101,1001,2461,4091,3171,4601,5011,4741,6821,3851,3071,3521,3901,4231,3901,2841,3681,4341,3481,8741,7591,6681,5171,5331,4701,3571,3691,3601,3701,2061,1991,1221,2721,2281,4971,329
       Other Current Assets 
290
284
297
291
293
456
492
663
407
658
636
539
359
485
384
574
505
572
696
666
525
418
560
504
587
779
639
567
512
0
480
440
307
207
434
379
159
174
437
416
0
0
338
63
53
90
26
32
16
96
32
11
113296163226905363338004164371741593794342073074404800512567639779587504560418525666696572505574384485359539636658407663492456293291297284290
   > Long-term Assets 
2,569
2,713
0
0
0
0
0
0
0
3,113
3,117
3,402
3,487
0
0
0
3,637
4,147
4,255
4,541
4,403
4,553
4,581
4,818
4,119
3,317
3,339
3,358
3,259
0
4,359
5,213
5,001
3,168
3,496
3,385
2,837
2,733
2,589
2,462
2,451
2,612
2,541
2,422
2,342
2,172
2,105
2,102
1,983
1,869
1,776
1,775
1,7751,7761,8691,9832,1022,1052,1722,3422,4222,5412,6122,4512,4622,5892,7332,8373,3853,4963,1685,0015,2134,35903,2593,3583,3393,3174,1194,8184,5814,5534,4034,5414,2554,1473,6370003,4873,4023,1173,11300000002,7132,569
       Property Plant Equipment 
1,496
1,517
1,356
1,246
1,238
1,134
1,033
928
851
830
742
847
781
714
630
546
459
864
848
963
951
1,011
997
1,001
339
321
336
384
347
469
652
1,546
1,475
1,385
1,697
1,613
568
534
492
451
1,078
1,252
1,183
1,113
1,043
975
919
902
846
772
706
746
7467067728469029199751,0431,1131,1831,2521,0784514925345681,6131,6971,3851,4751,5466524693473843363213391,0019971,0119519638488644595466307147818477428308519281,0331,1341,2381,2461,3561,5171,496
       Intangible Assets 
1,057
1,180
1,419
1,589
1,652
1,634
1,768
1,947
2,036
2,250
2,342
2,522
2,649
2,795
2,863
2,980
3,121
3,223
3,344
3,520
3,394
3,484
3,526
3,760
3,706
2,922
2,928
2,910
2,848
2,674
2,700
2,790
2,691
1,335
1,351
1,345
1,266
1,262
1,242
1,228
962
949
933
917
896
878
858
837
817
800
779
758
7587798008178378588788969179339499621,2281,2421,2621,2661,3451,3511,3352,6912,7902,7002,6742,8482,9102,9282,9223,7063,7603,5263,4843,3943,5203,3443,2233,1212,9802,8632,7952,6492,5222,3422,2502,0361,9471,7681,6341,6521,5891,4191,1801,057
       Long-term Assets Other 
16
16
0
0
0
0
0
0
0
33
33
33
57
0
0
0
57
60
63
58
58
58
58
57
74
74
75
64
64
0
1,007
784
745
358
375
356
1,003
937
855
783
365
372
390
359
369
286
328
326
288
297
260
240
2402602972883263282863693593903723657838559371,0033563753587457841,0070646475747457585858586360570005733333300000001616
> Total Liabilities 
3,303
2,189
1,958
2,237
1,964
2,187
1,594
2,576
6,389
7,021
6,048
2,039
2,269
6,858
6,772
6,080
6,396
5,544
21,240
8,843
7,115
3,601
7,217
6,021
8,139
4,800
5,829
6,773
5,939
5,259
5,477
9,732
8,936
9,508
9,719
10,388
5,427
5,320
6,417
5,621
9,294
9,534
10,007
9,834
9,694
9,655
9,787
9,632
9,500
9,577
9,633
9,610
9,6109,6339,5779,5009,6329,7879,6559,6949,83410,0079,5349,2945,6216,4175,3205,42710,3889,7199,5088,9369,7325,4775,2595,9396,7735,8294,8008,1396,0217,2173,6017,1158,84321,2405,5446,3966,0806,7726,8582,2692,0396,0487,0216,3892,5761,5942,1871,9642,2371,9582,1893,303
   > Total Current Liabilities 
3,303
2,189
1,958
2,237
1,964
2,187
1,594
2,576
6,389
7,021
6,048
2,039
2,269
6,858
6,772
6,080
6,396
5,544
21,240
8,843
7,115
3,601
7,217
6,021
8,139
4,800
5,829
6,773
5,939
5,077
4,466
4,458
3,707
1,913
4,205
4,081
3,852
1,483
4,721
4,431
4,349
4,284
4,811
4,694
4,613
4,635
4,831
4,744
4,682
4,832
4,966
5,024
5,0244,9664,8324,6824,7444,8314,6354,6134,6944,8114,2844,3494,4314,7211,4833,8524,0814,2051,9133,7074,4584,4665,0775,9396,7735,8294,8008,1396,0217,2173,6017,1158,84321,2405,5446,3966,0806,7726,8582,2692,0396,0487,0216,3892,5761,5942,1871,9642,2371,9582,1893,303
       Short-term Debt 
0
0
0
0
0
0
0
0
0
4,925
4,302
0
0
0
0
0
1,354
239
19,616
7,148
5,419
2,045
4,077
2,493
3,667
3,113
2,758
2,779
2,021
0
1,148
837
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000008371,14802,0212,7792,7583,1133,6672,4934,0772,0455,4197,14819,6162391,354000004,3024,925000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
2,700
0
351
1,100
0
0
294
1,827
1,848
0
2,395
2,422
2,505
141
3,071
2,882
2,912
2,943
3,225
3,258
3,291
3,325
3,357
3,390
3,424
3,457
3,490
3,523
3,5233,4903,4573,4243,3903,3573,3253,2913,2583,2252,9432,9122,8823,0711412,5052,4222,39501,8481,827294001,10035102,7002,00000000000000000000000000
       Accounts payable 
1,888
1,287
719
995
1,056
969
430
743
522
1,843
1,496
1,789
2,019
670
1,765
580
4,792
5,055
1,374
1,445
1,446
1,306
2,890
3,278
4,222
1,437
2,821
3,744
3,668
458
2,774
731
722
654
534
579
3,213
746
3,924
3,872
611
508
635
477
378
322
351
331
303
364
360
377
3773603643033313513223784776355086113,8723,9247463,2135795346547227312,7744583,6683,7442,8211,4374,2223,2782,8901,3061,4461,4451,3745,0554,7925801,7656702,0191,7891,4961,8435227434309691,0569957191,2871,888
       Other Current Liabilities 
1,415
902
1,239
1,242
908
1,218
1,164
1,833
5,867
253
250
250
250
6,188
5,007
3,238
250
250
250
250
250
250
250
250
250
250
250
250
250
1,995
544
837
250
250
250
250
639
737
797
559
250
250
250
250
250
250
250
250
0
0
0
0
00002502502502502502502502505597977376392502502502508375441,9952502502502502502502502502502502502502503,2385,0076,1882502502502535,8671,8331,1641,2189081,2421,2399021,415
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,011
5,274
5,229
7,595
5,514
6,307
1,575
3,837
1,696
1,190
4,945
5,250
5,196
5,140
5,081
5,020
4,956
4,888
4,818
4,745
4,667
4,586
4,5864,6674,7454,8184,8884,9565,0205,0815,1405,1965,2504,9451,1901,6963,8371,5756,3075,5147,5955,2295,2741,011000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
207
97
322
40
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000004032297207000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
4,941
4,941
4,941
4,941
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,300
4,300
4,300
4,300
4,300
4,300
4,300
4,300
4,300
0
0
0
0
0
0
0
0
0
0
0
0
0000000000004,3004,3004,3004,3004,3004,3004,3004,3004,3000000000000000000004,9414,9414,9414,941000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
182
0
0
0
207
97
322
40
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000403229720700018200000000000000000000000000000
> Total Stockholder Equity
4,809
5,136
8,628
6,672
5,152
3,183
5,221
3,522
538
-4,223
-4,337
-365
-846
321
0
805
834
1,594
-12,852
-982
425
3,444
638
1,593
-186
2,064
1,639
1,643
2,786
2,532
3,186
-1,191
-676
-2,888
-2,843
-3,605
-3,876
-4,333
-4,698
-4,310
-4,357
-4,588
-4,506
-4,418
-4,652
-4,520
-4,446
-3,846
-3,859
-4,187
-4,264
-4,016
-4,016-4,264-4,187-3,859-3,846-4,446-4,520-4,652-4,418-4,506-4,588-4,357-4,310-4,698-4,333-3,876-3,605-2,843-2,888-676-1,1913,1862,5322,7861,6431,6392,064-1861,5936383,444425-982-12,8521,5948348050321-846-365-4,337-4,2235383,5225,2213,1835,1526,6728,6285,1364,809
   Common Stock
77
79
87
87
87
87
112
113
134
151
157
214
224
239
262
274
2
3
3
3
4
4
4
4
4
6
6
6
7
7
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
0
0
8
0
0
0
0
000080088888888888888877666444443332274262239224214157151134113112878787877977
   Retained Earnings Total Equity000000000000-109,498-109,714-109,115-108,394-107,850-106,764-106,391-103,677-103,680-107,5690-105,635-105,756-105,362-104,532-103,143-100,979-101,547-98,463-100,624-101,038-111,957-97,384-95,852000-90,150-88,116-83,706-82,2710000000-57,723-55,051
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000
   Capital Surplus 
59,780
62,777
0
0
0
0
0
0
0
77,897
79,212
87,537
89,080
0
0
0
96,679
98,970
99,097
100,048
101,040
101,898
102,176
102,563
102,948
106,585
106,990
107,388
108,409
0
110,742
102,476
102,988
103,490
103,908
104,232
104,505
104,769
105,003
105,175
0
0
0
0
0
0
0
0
0
0
0
0
000000000000105,175105,003104,769104,505104,232103,908103,490102,988102,476110,7420108,409107,388106,990106,585102,948102,563102,176101,898101,040100,04899,09798,97096,67900089,08087,53779,21277,897000000062,77759,780
   Treasury Stock0000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 0000000000000000000000000000000000000000000000000000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,789
Cost of Revenue-3,181
Gross Profit4,6084,608
 
Operating Income (+$)
Gross Profit4,608
Operating Expense-8,452
Operating Income-663-3,844
 
Operating Expense (+$)
Research Development511
Selling General Administrative4,760
Selling And Marketing Expenses0
Operating Expense8,4525,271
 
Net Interest Income (+$)
Interest Income0
Interest Expense-139
Other Finance Cost-0
Net Interest Income-139
 
Pretax Income (+$)
Operating Income-663
Net Interest Income-139
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-131-1,334
EBIT - interestExpense = -139
-131
8
Interest Expense139
Earnings Before Interest and Taxes (EBIT)08
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-131
Tax Provision-0
Net Income From Continuing Ops-131-131
Net Income-131
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net671139
 

Technical Analysis of International Stem Cell Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of International Stem Cell Corp. The general trend of International Stem Cell Corp is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine International Stem Cell Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of International Stem Cell Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.09 < 0.09 < 0.1.

The bearish price targets are: 0.06 > 0.06 > 0.06.

Tweet this
International Stem Cell Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of International Stem Cell Corp. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

International Stem Cell Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of International Stem Cell Corp. The current macd is 0.00380019.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the International Stem Cell Corp price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for International Stem Cell Corp. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the International Stem Cell Corp price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
International Stem Cell Corp Daily Moving Average Convergence/Divergence (MACD) ChartInternational Stem Cell Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of International Stem Cell Corp. The current adx is 21.17.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy International Stem Cell Corp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
International Stem Cell Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of International Stem Cell Corp. The current sar is 0.0599421.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
International Stem Cell Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of International Stem Cell Corp. The current rsi is 63.20. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
International Stem Cell Corp Daily Relative Strength Index (RSI) ChartInternational Stem Cell Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of International Stem Cell Corp. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the International Stem Cell Corp price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
International Stem Cell Corp Daily Stochastic Oscillator ChartInternational Stem Cell Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of International Stem Cell Corp. The current cci is 164.68.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
International Stem Cell Corp Daily Commodity Channel Index (CCI) ChartInternational Stem Cell Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of International Stem Cell Corp. The current cmo is 33.61.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
International Stem Cell Corp Daily Chande Momentum Oscillator (CMO) ChartInternational Stem Cell Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of International Stem Cell Corp. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
International Stem Cell Corp Daily Williams %R ChartInternational Stem Cell Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of International Stem Cell Corp.

International Stem Cell Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of International Stem Cell Corp. The current atr is 0.00762835.

International Stem Cell Corp Daily Average True Range (ATR) ChartInternational Stem Cell Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of International Stem Cell Corp. The current obv is 64,486.

International Stem Cell Corp Daily On-Balance Volume (OBV) ChartInternational Stem Cell Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of International Stem Cell Corp. The current mfi is 85.53.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
International Stem Cell Corp Daily Money Flow Index (MFI) ChartInternational Stem Cell Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for International Stem Cell Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

International Stem Cell Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of International Stem Cell Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.198
Ma 20Greater thanMa 500.068
Ma 50Greater thanMa 1000.071
Ma 100Greater thanMa 2000.080
OpenGreater thanClose0.090
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of International Stem Cell Corp with someone you think should read this too:
  • Are you bullish or bearish on International Stem Cell Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about International Stem Cell Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about International Stem Cell Corp

I send you an email if I find something interesting about International Stem Cell Corp.


Comments

How you think about this?

Leave a comment

Stay informed about International Stem Cell Corp.

Receive notifications about International Stem Cell Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.